A graduate of the University of Alabama, Dr. James E. Kendrick IV brings years of expertise to the Florida Hospital Cancer Institute, particularly in the area of uterine cancer and gynecologic oncology.
After earning his medical degree at the University of Alabama’s School of Medicine, Dr. Kendrick completed his residency in Obstetrics and Gynecology at the university’s hospital. He also completed his three-year fellowship there. Dr. Kendrick’s interests include robotic surgery and gynecological malignancy management.
He is a noted author of peer-reviewed articles, publications and abstracts, with nearly 50 published works to his credit.
Fellowship: Gynecologic Oncology, University of Alabama Hospital at Birmingham
Residency: Obstetrics and Gynecology, University of Alabama Hospital
Medical School: University of Alabama at Birmingham, School of Medicine
Undergraduate: University of Alabama
American College of Obstetricians and Gynecologists
Obstetrics and Gynecology (ABOG) – board eligible
Gynecology Oncology – board eligible
American College of Obstetricians & Gynecology
American Society of Clinical Oncology
Society of Gynecologic Oncologists
Dr. Kendrick has authored and co-authored nearly 50 works for publication, including:
Leath CA III, Numnum TM, Kendrick JE IV, Frederick PJ, Rocconi RP, Conner MG, Straughn JM Jr. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: Implications for adjuvant therapy. International Journal of Gynecologic Cancer.
Kendrick JE, Numnum TM, Estes JM, Kimball KJ, Leath CA, Straughn JM. Conservative Management of Postoperative Fever in Gynecologic Patients Undergoing Major Abdominal or Vaginal Surgery. Journal of the American College of Surgeons.
Kendrick JE, Straughn JM, Oliver PG, Wang W, Nan L, Grizzle WE, Stockard CR, Alvarez RD, Buchsbaum DJ. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model. Gynecologic Oncology; 108(3): 591-7, March 2008.
Kendrick JE, Huh WK. Treatment Considerations in Advanced Endometrial Cancer. Current Oncology Reports 2007; 9(6): 494-498.
Kendrick JE, Estes JM, Straughn JM, Alvarez RD, Buchsbaum DJ. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and its Therapeutic Potential in Breast and Gynecologic Cancers. Gynecologic Oncology; 106(3):61421, June 2007.